UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000059939 |
|---|---|
| Receipt number | R000068555 |
| Scientific Title | Efficacy test of skin care products for sensitive skin |
| Date of disclosure of the study information | 2025/12/05 |
| Last modified on | 2025/12/02 10:25:45 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Efficacy test of skin care products for sensitive skin
Acronym
Efficacy test of skin care products for sensitive skin
Scientific Title
Efficacy test of skin care products for sensitive skin
Scientific Title:Acronym
Efficacy test of skin care products for sensitive skin
Region
| Japan |
Condition
Condition
Not applicable
Classification by specialty
| Not applicable | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To study the effectiveness of skin care products in improving sensitive skin symptoms.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Not applicable
Assessment
Primary outcomes
Lactic acid sting test score values before and after 4 weeks of skin care product use
Key secondary outcomes
-Stratum corneum moisture content value
-TEWL value
-Neurometer value
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
YES
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
3
Purpose of intervention
Treatment
Type of intervention
| Other |
Interventions/Control_1
Apply moisturizer skin care products to the face twice a day for 4wks.
Interventions/Control_2
Apply placebo to the face twice a day for 4wks.
Interventions/Control_3
Apply placebo to the face twice a day for 4wks.
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 59 | years-old | >= |
Gender
Female
Key inclusion criteria
1. Japanese women between 20 and 59 years old.
2. Those who usually use lotion at least 4 days a week.
3. Those whose awareness of facial skin sensitivity is "sensitive" or "somewhat sensitive" out of four levels: "sensitive," "somewhat sensitive," "somewhat not sensitive," or "not sensitive.
4. Those who experience dryness symptoms on the face at least one day a week.
5. Those who have sensitivity symptoms (redness, itching, stinging, tingling, burning) on the face at least one day per week.
6. Those who feel/have felt irritation such as tingling or burning on the face using cosmetics at least one day a week.
Key exclusion criteria
1.Those who are pregnant or may be pregnant, breastfeeding, or less than 6 months postpartum
2.Those who have participated in other studies (all studies using cosmetics, food, pharmaceuticals, quasi-drugs, medical devices, etc.) within the past 4 weeks, or those who have participated in other human studies during the scheduled implementation period of this study. Those who are planning to participate.
3.Those with skin symptoms such as atopic dermatitis or contact dermatitis.
4.Those with a history of allergies or rashes to cosmetics, adhesive tapes, medical tapes, etc.
5.Those with facial skin abnormalities (rash, eczema, wounds, bruises, etc.).
6.Those who have had severe sunburn on their face within the past month
7.Those who are visiting a medical institution due to poor physical condition or skin disease.
8.Those using cosmetics, quasi-drugs, or pharmaceuticals that may affect the test (peels, steroids, anti-inflammatory drugs, topical drugs, antibacterial drugs, etc.).
9.Those with seasonal allergies such as severe hay fever.
10.Those who have regular use of medications (including over-the-counter sleeping pills, anti-allergic medications, pain relievers, hormones, laxatives, intestinal preparations, antibiotics, and medications for other ailments) during the past 3 months.
11.Those who have received cosmetic treatment for the face (laser treatment, collagen injection, etc.).
12.Those who have had aesthetic treatment on their face within the past 1 month
13.Those who use home facial beauty devices or beauty equipment
14.Those who have a habit of smoking.
15.Persons involved in this study.
16.Those who are engaged in a related industry (such as the pharmaceutical industry, cosmetics industry, advertising magazine, etc.)
17.Those who are deemed unsuitable for research participation by the research director due to violation of compliance obligations, etc.
18.Those who use skin care products containing cetyl PG hydroxyethyl palmitamide
Target sample size
99
Research contact person
Name of lead principal investigator
| 1st name | Kaori |
| Middle name | |
| Last name | Tojo |
Organization
Kao Corporation
Division name
Skin Care Research Lab.
Zip code
131-8501
Address
2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, JAPAN
TEL
+81-3-5630-7286
tojo.kaori@kao.com
Public contact
Name of contact person
| 1st name | Shiori |
| Middle name | |
| Last name | Yoshikawa |
Organization
Kao Corporation
Division name
Skin Care Research Lab.
Zip code
131-8501
Address
2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, JAPAN
TEL
+81-3-5630-7286
Homepage URL
yoshikawa.shiori@kao.com
Sponsor or person
Institute
Kao Corporation
Institute
Department
Personal name
Funding Source
Organization
Kao Corporation
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Human Research Ethics Committee, Kao Corporation
Address
2-1-3 Bunka, Sumida-ku, Tokyo 131-8501, JAPAN
Tel
+81-3-5630-9064
morisaki.naoko@kao.com
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 12 | Month | 05 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2025 | Year | 10 | Month | 24 | Day |
Date of IRB
| 2025 | Year | 10 | Month | 22 | Day |
Anticipated trial start date
| 2025 | Year | 12 | Month | 05 | Day |
Last follow-up date
| 2026 | Year | 03 | Month | 01 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2025 | Year | 12 | Month | 02 | Day |
Last modified on
| 2025 | Year | 12 | Month | 02 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068555
